Notably, the results demonstrated that the prognostic value of TRF2/VEGF-A association is not affected by the mutational state of BRAF (Supplementary Fig. S13), definitively confirming the role of TRF2/VEGF-A as independent prognostic factors in CRC patients. The gene discussed is BRAF; the disease is colorectal carcinoma.